-
Loading metrics
Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
-
Giulia Morsica ,
Roles Conceptualization, Data curation, Investigation, Methodology, Supervision, Writing – original draft
* E-mail: morsica.giulia@hsr.it
Affiliation Division of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
⨯ - Laura Galli,
- Emanuela Messina,
- Antonella Castagna,
- Sabrina Bagaglio,
- Stefania Salpietro,
- Della Torre Liviana,
- Caterina Uberti-Foppa,
- Hamid Hasson
https://orcid.org/0000-0003-4891-5376
Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
- Giulia Morsica,
- Laura Galli,
- Emanuela Messina,
- Antonella Castagna,
- Sabrina Bagaglio,
- Stefania Salpietro,
- Della Torre Liviana,
- Caterina Uberti-Foppa,
- Hamid Hasson
x
- Published: February 3, 2022
- https://doi.org/10.1371/journal.pone.0262917